Literature DB >> 23150629

Accuracy and reproducibility of automated drusen segmentation in eyes with non-neovascular age-related macular degeneration.

Muneeswar Gupta Nittala1, Humberto Ruiz-Garcia, Srinivas R Sadda.   

Abstract

PURPOSE: To evaluate the accuracy and reproducibility of drusen quantification by an automated drusen segmentation algorithm in spectral domain optical coherence tomography (SD-OCT) images of eyes with non-neovascular age-related macular degeneration (AMD).
METHODS: Drusen segmentation was performed using both a commercial automated algorithm (Cirrus OCT RPE analysis tool) and manual segmentation in 44 eyes of 30 subjects with dry AMD who underwent volume OCT scanning. The drusen (space between outer RPE layer and Bruch's membrane) was segmented automatically using an automated RPE tool and manually by 3D-OCTOR software. Drusen area and volume were calculated in all eyes. Age and visual acuity data were also collected. Reproducibility of manual and automated measurements was assessed by intraclass correlation (ICC).
RESULTS: The mean age of subjects was 78.24 (± 9.4; range, 56-97 years). The mean logMAR (logarithm of the minimum angle of resolution) visual acuity was 0.4 (Snellen equivalent, ~20/50) (standard deviation, 0.40; range, 0-1.3). The mean (standard deviation) drusen area was 5.05 (3.67) mm(2) with manual segmentation and 4.66 (3.51) mm(2) with the automated RPE tool; the absolute difference was 2.63 (2.5) mm(2). The mean drusen volume was 1.49 (0.42) mm(3) with manual segmentation and 1.42 (0.43) mm(3) with the automated RPE tool; the absolute difference was 1.42 (0.43) mm(3). The agreement between manual and automated measurements of drusen volume (highest ICC = 0.95) was better than the agreement for drusen area (ICC = 0.65).
CONCLUSIONS: The quantification of drusen area and volume using an automated RPE yielded better agreement for volume than for area when compared with human expert manual segmentation. Using this software, drusen volume measurements may be a useful tool for quantifying drusen burden in clinical trials and clinical practice.

Entities:  

Mesh:

Year:  2012        PMID: 23150629     DOI: 10.1167/iovs.12-10582

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  20 in total

Review 1.  Molecular imaging of retinal disease.

Authors:  Megan E Capozzi; Andrew Y Gordon; John S Penn; Ashwath Jayagopal
Journal:  J Ocul Pharmacol Ther       Date:  2013-02-19       Impact factor: 2.671

2.  Change in drusen area over time compared using spectral-domain optical coherence tomography and color fundus imaging.

Authors:  Giovanni Gregori; Zohar Yehoshua; Carlos Alexandre de Amorim Garcia Filho; SriniVas R Sadda; Renata Portella Nunes; William J Feuer; Philip J Rosenfeld
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-10-21       Impact factor: 4.799

3.  Drusen and RPE atrophy automated quantification by optical coherence tomography in an elderly population.

Authors:  B Diniz; D C Rodger; V R Chavali; T MacKay; S Y Lee; D Stambolian; S V R Sadda
Journal:  Eye (Lond)       Date:  2014-11-07       Impact factor: 3.775

4.  ASSOCIATION OF DRUSEN VOLUME WITH CHOROIDAL PARAMETERS IN NONNEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

Authors:  Siva Balasubramanian; Jianqin Lei; Muneeswar G Nittala; Swetha B Velaga; Jonathan Haines; Margaret A Pericak-Vance; Dwight Stambolian; SriniVas R Sadda
Journal:  Retina       Date:  2017-10       Impact factor: 4.256

5.  Agreement and reproducibility of retinal pigment epithelial detachment volumetric measurements through optical coherence tomography.

Authors:  Joseph Ho; Mehreen Adhi; Caroline Baumal; Jonathan Liu; James G Fujimoto; Jay S Duker; Nadia K Waheed
Journal:  Retina       Date:  2015-03       Impact factor: 4.256

6.  Choriocapillaris flow impairment predicts the development and enlargement of drusen.

Authors:  Marco Nassisi; Tudor Tepelus; Muneeswar Gupta Nittala; Srinivas R Sadda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-07-01       Impact factor: 3.117

7.  Association of OCT derived drusen measurements with AMD associated-genotypic SNPs in Amish population.

Authors:  Venkata Ramana Murthy Chavali; Bruno Diniz; Jiayan Huang; Gui-Shuang Ying; SriniVas R Sadda; Dwight Stambolian
Journal:  J Clin Med       Date:  2015       Impact factor: 4.241

8.  AMISH EYE STUDY: Baseline Spectral Domain Optical Coherence Tomography Characteristics of Age-Related Macular Degeneration.

Authors:  Muneeswar G Nittala; Yeunjoo E Song; Rebecca Sardell; Larry D Adams; Samuel Pan; Swetha B Velaga; Violet Horst; Debra Dana; Laura Caywood; Renee Laux; Denise Fuzzell; Sarada Fuzzell; William K Scott; Jessica N Cooke Bailey; Robert P Igo; Jonathan Haines; Margaret A Pericak-Vance; SriniVas R Sadda; Dwight Stambolian
Journal:  Retina       Date:  2019-08       Impact factor: 3.975

Review 9.  Cellular and Molecular Pathology of Age-Related Macular Degeneration: Potential Role for Proteoglycans.

Authors:  Othman Al Gwairi; Lyna Thach; Wenhua Zheng; Narin Osman; Peter J Little
Journal:  J Ophthalmol       Date:  2016-08-01       Impact factor: 1.909

Review 10.  Algorithms for the Automated Analysis of Age-Related Macular Degeneration Biomarkers on Optical Coherence Tomography: A Systematic Review.

Authors:  Maximilian W M Wintergerst; Thomas Schultz; Johannes Birtel; Alexander K Schuster; Norbert Pfeiffer; Steffen Schmitz-Valckenberg; Frank G Holz; Robert P Finger
Journal:  Transl Vis Sci Technol       Date:  2017-07-18       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.